UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $90.00

Colgate-Palmolive (NYSE:CL) had its price objective decreased by UBS Group from $92.00 to $90.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price target points to a potential upside of 20.10% from the company’s previous close.

A number of other equities analysts have also issued reports on CL. Bank of America lowered their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday. Barclays lowered their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a report on Friday, October 10th. Finally, Raymond James Financial lowered their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Nine investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $90.00.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded down $2.11 during midday trading on Monday, reaching $74.94. 10,801,867 shares of the company were exchanged, compared to its average volume of 5,446,842. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive has a 1 year low of $74.54 and a 1 year high of $100.18. The stock has a fifty day simple moving average of $80.45 and a 200 day simple moving average of $86.28. The stock has a market cap of $60.56 billion, a P/E ratio of 21.05, a PEG ratio of 4.44 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same quarter last year, the company posted $0.91 earnings per share. The business’s revenue was up 1.9% on a year-over-year basis. On average, research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CL. Norges Bank bought a new position in shares of Colgate-Palmolive in the second quarter valued at approximately $960,390,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of Colgate-Palmolive by 18.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after acquiring an additional 5,269,140 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of Colgate-Palmolive by 242.3% in the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock valued at $483,962,000 after acquiring an additional 3,768,784 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 3,052.2% in the third quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock valued at $215,602,000 after acquiring an additional 2,611,485 shares in the last quarter. Finally, Nuveen LLC bought a new position in shares of Colgate-Palmolive in the first quarter valued at approximately $217,593,000. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.